healthliberal
Continuous Glucose Sensors Help Type 2 Patients Beat Sugar Levels
United KingdomMonday, April 27, 2026
A recent study published on April 23 shows that people with type 2 diabetes who use continuous glucose monitors (CGMs) achieve better blood‑sugar control than those relying on traditional finger‑prick tests.
Study Design
- Participants: Over 300 patients
- Duration: 32 weeks
- Groups:
- Half wore CGMs from the start.
- Half continued conventional testing.
Key Findings
| Phase | Intervention | Outcome |
|---|---|---|
| Weeks 1‑16 | CGM users | Lowered HbA1c scores without medication changes |
| Weeks 17‑32 | Doctors prescribed new treatments | CGM users saw additional improvements |
- Real‑time data on wrist devices or phones helped patients adjust food, activity, and insulin use.
- Continuous monitoring provides a near‑real‑time view of glucose trends, reducing the risk of dangerous highs or lows that can lead to heart disease or vision loss.
Implications
- CGMs are already standard for type 1 diabetes but less common in type 2 care.
- The study suggests many type 2 patients could benefit from this technology.
- Experts note that while the results support wider CGM adoption, cost‑effectiveness still needs further study.
The data demonstrate that simple tools can empower patients to manage their condition more safely and with fewer finger‑pricks.
Actions
flag content
